Labcorp and Swedish Extend Laboratory Services Relationship, Providing Continued Access to High-Quality Diagnostics and COVID-19 Testing

October 19, 2020

LabCorp launches quantitative antibody test to assess effectiveness of COVID-19 vaccines in clinical trials

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 19, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care, today announced a test that provides a quantitative measurement of an individual’s SARS-CoV-2 IgG antibodies. LabCorp’s Cov2Quant™ IgG test, which is available only for use in clinical trials and research, was developed to specifically detect and quantify antibodies to SARS-CoV-2, the virus that causes COVID-19. The level of antibodies is an important indicator of the strength of a person’s immune response, which can help determine the effectiveness of vaccines and therapies.

Labcorp Is First to Provide Consumers With Secure Access to Their Diagnostic Test Results Through CommonHealth

October 13, 2020

LabCorp is first to provide consumers with secure access to their diagnostic test results through CommonHealth

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 13, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and The Commons Project , a non-profit public trust dedicated to building global digital services and platforms for the common good, today announced a strategic partnership to allow people to securely access their LabCorp test results via CommonHealth, the privacy-preserving Android app that enables users to safely collect, store, and use their personal health information. LabCorp is the first major commercial lab to integrate with CommonHealth, which is also working with a wide range of other health care providers.

Labcorp and HealthEC Launch Transformative Oncology Care Module

October 9, 2020

Labcorp and HealthEC launch transformative oncology care module

BURLINGTON, N.C. & EDISON, N.J. --(BUSINESS WIRE)--Oct. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and HealthEC, LLC , a leading provider of population health management solutions, today announced the launch of LabCorp’s Care Intelligence Oncology Module (Oncology Care Module). LabCorp’s Oncology Care Module is designed to empower oncologists to improve patient outcomes and achieve cost-savings by making it easier to access and compare key data points and performance metrics. Available exclusively through LabCorp , the single-platform solution connects claims and clinical systems using the LabCorp Care Intelligence™ application, powered by HealthEC®.